Co-Diagnostics's market cap is currently ―. The company's EPS TTM is $-1.175; its P/E ratio is -0.98; Co-Diagnostics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.46M	$ 197.81K	$ 601.96K	$ 1.40M	$ 5.09M
Gross Profit	$ 2.20M	$ 197.81K	$ 99.72K	$ 885.71K	$ 4.33M
EBIT	$ -8.10M	$ -11.16M	$ -8.02M	$ -26.33M	$ -6.54M
EBITDA	$ -7.80M	$ -10.85M	$ -7.70M	$ -26.03M	$ -6.22M
Net Income Common Stockholders	$ -5.98M	$ -8.92M	$ 10.83M	$ -21.91M	$ -1.36M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 63.43M	$ 69.14M	$ 75.28M	$ 81.26M	$ 86.49M
Total Assets	$ 108.68M	$ 112.80M	$ 114.49M	$ 123.09M	$ 147.84M
Total Debt	$ 3.04M	$ 3.23M	$ 935.43K	$ 347.92K	$ 418.82K
Net Debt	$ -60.38M	$ -65.91M	$ -74.34M	$ -80.91M	$ -86.07M
Total Liabilities	$ 9.19M	$ 9.37M	$ 4.18M	$ 8.57M	$ 12.90M
Stockholders Equity	$ 99.49M	$ 103.43M	$ 110.63M	$ 114.52M	$ 134.95M
Cash Flow	-
Free Cash Flow	$ -6.83M	$ -5.69M	$ -5.68M	$ -4.30M	$ 888.27K
Operating Cash Flow	$ -6.59M	$ -5.21M	$ -5.50M	$ -4.01M	$ 1.12M
Investing Cash Flow	$ 3.17M	$ 13.24M	$ -10.63M	$ -53.31M	$ 4.74M
Financing Cash Flow	$ -166.33K	$ -555.73K	$ -482.20K	$ -1.22M	$ -10.39M

Currency in USD

Co-Diagnostics Earnings and Revenue History

Income Statement >

Co-Diagnostics Debt to Assets

Balance Sheet >

Co-Diagnostics Cash Flow

Cash Flow >

Co-Diagnostics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing